Effectiveness and Safety of Traditional Chinese Medicine Injection Combined with CF Chemotherapy Regimen in the Treatment of Breast Cancer:Network Meta-analysis and Trial Sequential Analysis

TIAN Jin-hui,GE Long,LOU Li-li,XIE Wen,GAN Yu-hong,PEI Gai-qin,WANG Quan,LIU Rui-feng,ZHANG Qiu-ning,WANG Xiao-hu,ZHANG Hong
DOI: https://doi.org/10.3969/j.issn.1007-9572.2016.27.014
2016-01-01
Abstract:Objective To assess the efficacy and safety of traditional Chinese medicine injection(TCMI)combined with CF chemotherapy(TCMI + CF)for breast cancer. Methods In October 2014,a computer - based retrieval was performed including CNKI,CBM,Wangfang Data knowledge Service Platform,VIP database,ISI Web of Knowledge,EMBase,PubMed and Cochrane Library,to include RCTs that comparing TCMI + CF and pure CF chemotherapy for breast cancer. Two evaluators conducted data extraction and quality evaluation separately. Stata 12. 0,WinBUGS 1. 4 and TSA were used to conduct network Meta analysis and trial sequential analysis. Results We included 26 RCTs involving 1 884 patients and 6 kinds of TCMI(Fufang Kushen injection,Kang'ai injection,Kanglaite injection,Aidi injection,Huachansu injection,Shenqifuzheng injection). The results of network Meta - analysis showed that Fufang Kushen and Kanglaite combined with CF chemotherapy were better than other injections in the improvement of overall effectiveness index and quality of life. However,Shenqifuzheng and Aidi combined with CF chemotherapy were better in reducing nausea and vomiting( grade Ⅲ - Ⅳ)and decrease in white blood cell count (grade Ⅲ - Ⅳ). Conclusion At present,there is still no strong evident that TCMI + CF is the best therapy in effective rate, improving quality of life,reducing nausea and vomiting,and inhibiting decrease in white blood cell count. Therefore,rational choice of drug should be made for patients in clinical practice.
What problem does this paper attempt to address?